Microrna-146 Family: Molecular Insights Into Their Role in Regulation of Signaling Pathways in Glioma Progression Publisher Pubmed



Mirzaei S¹ ; Ahangari F² ; Faramarzi F³ ; Khoshnazar SM⁴ ; Khormizi FZ⁵ ; Aghagolzadeh M⁶ ; Rostami M⁷ ; Asghariazar V⁹ ; Alimohammadi M¹⁰ ; Rahimzadeh P¹¹ ; Farahani N¹²
Source: Pathology, research and practice Published:2024

Abstract

Glioma is a highly lethal brain cancer in humans. Despite advancements in treatment, the prognosis for patients remains unfavorable. Epigenetic factors, along with their interactions and non-coding RNAs (ncRNAs), are crucial in glioma cells' development and aggressive characteristics. MicroRNAs (miRNAs) are a class of small non-coding RNAs (ncRNAs) that modulate the expression of various genes by binding to target mRNA molecules. They play a critical role in regulating essential biological mechanisms such as cell proliferation and differentiation, cell cycle, and apoptosis. MiR-146a/miR-146b is a significant and prevalent miRNA whose expression alterations are linked to various pathological changes in cancer cells, as well as the modulation of several cellular signaling pathways, including NF-κB, TGF-β, PI3K/Akt, and Notch-1. Scientists may identify novel targets in clinical settings by studying the complicated link between Mir-146a/mir-146b, drug resistance, molecular pathways, and pharmacological intervention in gliomas. Additionally, its interactions with other ncRNAs, such as circular RNA and long non-coding RNA, contribute to the pathogenesis of glioma. As well as miR-146 holds potential as both a diagnostic and therapeutic biomarker for patients with this condition. In the current review, we investigate the significance of miRNAs in the context of glioma, with a particular focus on the critical role of Mir-146a/mir-146b in glioma tumors. Additionally, we examined the clinical relevance of this miRNA, highlighting its potential implications for diagnosis and treatment. Copyright © 2024 Elsevier GmbH. All rights reserved.